Drug Profile
Phellodendrine
Alternative Names: OB 5Latest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Anti-inflammatories; Antiasthmatics; Antivirals; Quinolizines
- Mechanism of Action Immunomodulators; Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Asthma; Chronic hepatitis; Graft-versus-host disease; Hypersensitivity; Inflammation; Nephrotic syndrome
Most Recent Events
- 23 Jul 1998 No-Development-Reported for Allergy in Japan (Unknown route)
- 23 Jul 1998 No-Development-Reported for Asthma in Japan (Unknown route)
- 23 Jul 1998 No-Development-Reported for Chronic hepatitis in Japan (Unknown route)